All results
71 results
-
Clinical Trials
This research study is for individuals who have inflammatory bowel disease (IBD), including Crohn’s disease (CD), ulcerative colitis (UC), and Indeterminate…
-
Clinical Trials
This is an observational research study. Individuals are being asked to be a part of this study because they have non-alcoholic fatty liver disease (NAFLD).…
-
Clinical Trials
Study EP0162 is a double-blind, randomized, placebo-controlled, multi-center, parallel-group, Phase 3 study to investigate the efficacy and safety of Staccato…
-
Clinical Trials
This study is being done to learn more about olpasiran (AMG 890) in people with cardiovascular disease and elevated Lp(a). It will see if olpasiran (AMG 890)…
-
Clinical Trials
Adult patients with Gaucher Disease Type 1 who have previously received SRT (substrate replacement therapy) and are now receiving ERT (enzyme replacement…
-
Clinical Trials
This study will test whether the drug dapagliflozin is safe and has beneficial effects when added to conventional heart failure therapy in patients who have…
-
Clinical Trials
This study is being carried out to evaluate benralizumab (study drug) compared to placebo (an inactive substance) as a medicine to treat moderate to very…
-
Clinical Trials
Individuals diagnosed with COVID-19 are being asked to take part in a research study of an investigational drug called Asapiprant (BGE 175). This drug is being…
-
Clinical Trials
A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation–Associated Retinitis Pigmentosa
-
Clinical Trials
The purpose of this study is to see if the drug, CPI-1205, in combination with standard of care treatments enzalutamide or abiraterone/prednisone can improve…